Cosmetic Surgery Market Summary
The Global Cosmetic Surgery Market size was valued at USD 60.22 Billion in 2024, and the market is projected to grow from USD 64.83 Billion in 2025 to USD 135.51 Billion by 2035, registering a CAGR of 7.65% during the forecast period 2025–2035. North America led the market in 2024 with over 40.02% share of the global revenue.
The global market is expanding rapidly due to rising consumer preference for minimally invasive aesthetic procedures, increasing social media influence, and advancements in laser-based and image-guided technologies. Growing awareness of appearance enhancement and faster recovery solutions is accelerating adoption across both younger and aging populations.
According to the WHO Data Portal, noncommunicable diseases account for nearly 74% of global deaths annually, increasing long-term demand for reconstructive and aesthetic corrective procedures. Additionally, WHO estimates that over 1 billion people worldwide are aged 60 years and above, significantly boosting demand for age-related cosmetic and facial rejuvenation treatments.
Key Market Trends & Highlights
The Cosmetic Surgery Market is experiencing a dynamic shift towards non-invasive procedures and personalized treatments.
- Hospitals and dermatology clinics hold 64% share, driven by advanced infrastructure and availability of specialized professionals.
- North America leads with 40.02% share, while Europe holds USD 18.066 billion and 29.96% share in 2024.
- Invasive procedures dominate with 62% share, driven by strong demand for significant and long-lasting aesthetic transformations globally.
- Botox injections lead non-invasive segment with 58% share, supported by high repeat usage and increasing consumer acceptance.
Market Size & Forecast
| 2024 Market Size | 60.22 (USD Billion) |
| 2035 Market Size | 135.51 (USD Billion) |
| CAGR (2025 - 2035) | 7.65% |
Major Players
Companies such as Allergan (US), Galderma (CH), Revance Therapeutics (US), Medytox (KR), Ipsen (FR), Hugel (KR), Medytox (KR), Sientra (US), Croma-Pharma (AT) are some of the major participants in the global market.